• Slider home

IRBM

About us

IRBM Research and Development

The privately owned IRBM Group, a diversified industrial group operating within the biotech and pharmaceutical sector, is composed by IRBM, IRBM PROMIDIS, Advent and the CNCCS Consortium. IRBM is a the parent company dedicated to innovative preclinical drug discovery and development in areas of high unmet medical need, including neurodegenerative and rare and neglected diseases.

We are your “one-stop-shop” for all your preclinical drug development needs.
Our team of experienced scientists has a proven track record.

Areas of particular expertise include fully integrated small molecule and peptide-based drug discovery, peptide-based vaccines, ADMET optimization and biomarker development.

In particular we relish the challenge of poorly druggable targets.

Bio International Convention

14-02-2014

We will be present at the Bio International Convention, June 23-26 2013, San Diego, US

BioEurope Spring 2014

31-01-2014

We are present at the BioEurope Spring 2014, March 10-12 2014, Turin, Italy.

IRBM Partner CNR ISS CNCCS